HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Figures Only Full Text Full Text (PDF) Correspondence: Submit a response Alert me when this article is cited Alert me when Correspondence are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Tam, C. W.C. Articles by O’Brien, J. T. Search for Related Content PubMed PubMed Citation Articles by Tam, C. W.C. Articles by O’Brien, J. T. Related Collections MRI Volumetric MRI Parkinson's disease/Parkinsonism Parkinson's disease with dementia

Temporal lobe atrophy on MRI in Parkinson disease with dementia

A comparison with Alzheimer disease and dementia with Lewy bodies

From the Department of Psychiatry (Dr. Tam), Tai Po Hospital, Hong Kong; and Institute for Ageing and Health (Drs. Burton, McKeith, and O’Brien), University of Newcastle upon Tyne, and Department of Neurology (Dr. Burn), Regional Neurosciences Centre, Newcastle General Hospital, UK.

Address correspondence and reprint requests to Dr. J.T. O’Brien, Wolfson Research Centre, Newcastle General Hospital, Newcastle, NE4 6BE, UK; e-mail: j.t.o'brien{at}ncl.ac.uk

Objective: To investigate the extent of medial temporal lobe atrophy (MTA) on MRI in Parkinson disease (PD) with and without dementia compared with Alzheimer disease (AD) and dementia with Lewy bodies (DLB) and to determine whether MTA correlates with cognitive impairment in PD and PD dementia (PDD).

Methods: Coronal T1-weighted MRI scans were acquired from control subjects (n = 39) and patients with PD (n = 33), PDD (n = 31), DLB (n = 25), and AD (n = 31), diagnosed according to standardized clinical diagnostic criteria. Cognitive function was assessed using the Cambridge Cognitive Examination (CAMCOG), and MTA was rated visually using a standardized (Scheltens) scale.

Results: More severe MTA was seen in PDD (p = 0.007), DLB (p < 0.001), and AD (p < 0.001) vs control subjects. PD subjects had greater hippocampal atrophy than control subjects (p = 0.015) but less than subjects with DLB and AD, though not with PDD. MTA correlated with CAMCOG score and memory scores in the DLB group and with age in control, PDD, and AD groups. There were no correlations between MTA and cognitive impairment in PD, PDD, and AD. PDD and DLB had a similar profile of cognitive impairment and MTA.

Conclusions: Medial temporal lobe atrophy (MTA) was seen in cognitively intact older subjects with Parkinson disease (PD) and was not more pronounced in Parkinson disease dementia (PDD). Alzheimer disease (AD) and, to a lesser extent, dementia with Lewy bodies (DLB) showed more pronounced MTA. Results suggest early hippocampal involvement in PD and that when dementia develops in PD, anatomic structures apart from the hippocampus are predominantly implicated. Greater hippocampal involvement in AD vs PDD and DLB is consistent with clinical, cognitive, and pathologic differences between the disorders.

This article has been cited by other articles:

				S. A. Parashos, M. L. Johnson, C. Erickson-Davis, and C. L. Wielinski Assessing Cognition in Parkinson Disease: Use of the Cognitive Linguistic Quick Test J Geriatr Psychiatry Neurol, December 1, 2009; 22(4): 228 - 234. [Abstract] [PDF]

				S. S. Staekenborg, E. L.G.E. Koedam, W. J.P. Henneman, P. Stokman, F. Barkhof, P. Scheltens, and W. M. van der Flier Progression of Mild Cognitive Impairment to Dementia: Contribution of Cerebrovascular Disease Compared With Medial Temporal Lobe Atrophy Stroke, April 1, 2009; 40(4): 1269 - 1274. [Abstract] [Full Text] [PDF]

				E. J. Burton, R. Barber, E. B. Mukaetova-Ladinska, J. Robson, R. H. Perry, E. Jaros, R. N. Kalaria, and J. T. O'Brien Medial temporal lobe atrophy on MRI differentiates Alzheimer's disease from dementia with Lewy bodies and vascular cognitive impairment: a prospective study with pathological verification of diagnosis Brain, January 1, 2009; 132(1): 195 - 203. [Abstract] [Full Text] [PDF]

				S. R. Brenner, M. K. Beyer, and D. Aarsland GRAY MATTER ATROPHY IN PARKINSON DISEASE WITH DEMENTIA AND DEMENTIA WITH LEWY BODIES Neurology, June 3, 2008; 70(23): 2265 - 2265. [Full Text] [PDF]

				M. K Beyer, C. C Janvin, J. P Larsen, and D. Aarsland A magnetic resonance imaging study of patients with Parkinson's disease with mild cognitive impairment and dementia using voxel-based morphometry J. Neurol. Neurosurg. Psychiatry, March 1, 2007; 78(3): 254 - 259. [Abstract] [Full Text] [PDF]

				J. L. Whitwell, S. D. Weigand, M. M. Shiung, B. F. Boeve, T. J. Ferman, G. E. Smith, D. S. Knopman, R. C. Petersen, E. E. Benarroch, K. A. Josephs, et al. Focal atrophy in dementia with Lewy bodies on MRI: a distinct pattern from Alzheimer's disease Brain, March 1, 2007; 130(3): 708 - 719. [Abstract] [Full Text] [PDF]

				C. Ballard, I. Ziabreva, R. Perry, J. P. Larsen, J. O'Brien, I. McKeith, E. Perry, and D. Aarsland Differences in neuropathologic characteristics across the Lewy body dementia spectrum Neurology, December 12, 2006; 67(11): 1931 - 1934. [Abstract] [Full Text] [PDF]

				C Geroldi, R Rossi, C Calvagna, C Testa, L Bresciani, G Binetti, O Zanetti, and G B Frisoni Medial temporal atrophy but not memory deficit predicts progression to dementia in patients with mild cognitive impairment J. Neurol. Neurosurg. Psychiatry, November 1, 2006; 77(11): 1219 - 1222. [Abstract] [Full Text] [PDF]

				P. S. R. Davidson, D. Anaki, J. A. Saint-Cyr, T. W. Chow, and M. Moscovitch Exploring the recognition memory deficit in Parkinson's disease: estimates of recollection versus familiarity Brain, July 1, 2006; 129(7): 1768 - 1779. [Abstract] [Full Text] [PDF]